Signifor is the First Approved Pituitary Targeted Medical Therapy for Cushing's disease. Signifor, a novel multireceptor-targeted somatostatin analogue, binds and activates 4 of the 5 ssts, with the highest affinity for sst5, resulting in inhibition of adrenocorticotropic hormone (ACTH) secretion. Signifor represents the first specific treatment for ACTH-secreting pituitary adenomas and will be the first approved medical treatment for Cushing's disease. Get important safety information at http://www.signifor.com/about/safety.jsp
DISCLAIMER: DMOZing.com is not affiliated in any way, shape, or form with DMOZ, AOL, Netscape, their management, entities or their official websites. Links to external websites on this website does not constitute endorsement.
